logo

FDA Calendar

Share
Company Name Mesoblast Limited
Drug Name Ryoncil (BLA)
Event Name FDA decision on Ryoncil for the treatment of children with steroid-refractory acute graft versus host disease
Event Date 09/30/2020
Outcome Date
Outcome
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar